Latest News In Cloud AI - Healthcare Embraces GenAI Amid Infrastructure Challenges

A recent study by Nutanix has highlighted the accelerated adoption of Generative AI (GenAI) and containerization within the healthcare sector, while also identifying significant challenges in the modernization of IT infrastructure needed to support these technologies. According to the report, 99% of healthcare organizations are leveraging GenAI applications, yet nearly all face data security and integration challenges when scaling these workloads. The study emphasizes the necessity for enhanced data governance and modernized infrastructure to fully realize the benefits of GenAI, given its critical impact on patient outcomes. Additionally, the expansion of containerization and Kubernetes deployments is noted as a significant trend accommodating the growing cloud native applications.

• Nutanix (NasdaqGS:NTNX) last closed at $76.80 up 1.8%.

In other market news, Datadog (NasdaqGS:DDOG) was trading firmly up 14.9% and ending trading at $155.15. Meanwhile, VMware (NYSE:VMW) lagged, down 5% to close at $142.48.

Strong demand for IT modernization, driven by companies seeking alternatives, positions Nutanix for rapid growth opportunities. Discover the full narrative on how Nutanix could capitalize on this market shift.

To explore the shifting landscape of Cloud AI investments, revisit our Market Insights article, covering AI monetization and investor opportunities—read it before trends evolve further.

Best Cloud AI Stocks

• Microsoft (NasdaqGS:MSFT) settled at $498.84 up 1.6%, not far from its 52-week high. In the past three days, Microsoft advanced strategic collaborations focusing on AI healthcare solutions, enterprise content management, and data security with Lunit, M-Files, and Varonis.
• Apple (NasdaqGS:AAPL) finished trading at $213.55 up 0.5%.
• Alphabet (NasdaqGS:GOOGL) finished trading at $179.53 up 0.5%.

Next Steps

• Click here to unveil our expertly curated list of 167 Cloud AI Stocks including EPAM Systems, AppFolio and Hexaware Technologies.
• Curious About Other Options? AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sources:

• Simply Wall St
• "Nutanix Study Finds Adoption of GenAI and Containers in the Healthcare Sector Has Accelerated, But IT Infrastructure Modernization to Support it Lags Behind" from Nutanix, Inc. on GlobeNewswire (published 01 July 2025)

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com